Treatment of Primary Central Nervous System Germinomas With Short-course Induction Chemotherapy Followed by Low-dose Radiotherapy Without a Tumor Bed Boost: Prognostic Impact of Human Chorionic Gonadotropin. Issue 7 (October 2021)
- Record Type:
- Journal Article
- Title:
- Treatment of Primary Central Nervous System Germinomas With Short-course Induction Chemotherapy Followed by Low-dose Radiotherapy Without a Tumor Bed Boost: Prognostic Impact of Human Chorionic Gonadotropin. Issue 7 (October 2021)
- Main Title:
- Treatment of Primary Central Nervous System Germinomas With Short-course Induction Chemotherapy Followed by Low-dose Radiotherapy Without a Tumor Bed Boost
- Authors:
- Chou, Yung-Chih
Wu, Yao-Yu
Hung, Sheng-Ping
Tsang, Ngan-Ming
Pai, Ping-Ching
Jaing, Tang-Her
Lin, Chien-Yu
Hsieh, Cheng-En
Fan, Kang-Hsing
Kao, Wei-Heng
Tseng, Chen-Kan - Abstract:
- Abstract : Objective: To investigate the clinical utility of short-course induction chemotherapy followed by low-dose radiotherapy without a tumor bed boost in patients with primary central nervous system (CNS) germinomas. Methods: We retrospectively reviewed the clinical records of patients with primary CNS germinomas who received short-course induction chemotherapy (2 cycles of cisplatin 20 mg/m 2 plus etoposide 40 or 100 mg/m 2 for 5 days) followed by low-dose radiotherapy (dose: 2340 cGy) without a tumor bed boost. Disease-free survival and overall survival served as the main outcome measures. Results: Between February 2002 and June 2018, 24 patients (20 males and 4 females; median age: 14.1 y; age range: 7.9 to 21.2 y) with pathology-proven CNS germinomas were included. The median follow-up time was 106 months (range: 17 to 169 mo). Isolated and multifocal lesions were identified in 13 and 11 patients, respectively. Tumor location was as follows: pineal gland (n=17), suprasellar region (n=13), periventricular region (n=7), and basal ganglia (n=2). Five patients had increased levels (>5 mIU/mL) of beta-human chorionic gonadotropin (β-hCG), whereas alpha-fetoprotein concentrations were within the reference range in all participants. A total of 16 patients achieved remission after induction chemotherapy. The complete response rates of patients with increased and normal β-hCG levels were 40.0% and 72.2%, respectively ( P =0.208). Low-dose radiotherapy without a tumor bedAbstract : Objective: To investigate the clinical utility of short-course induction chemotherapy followed by low-dose radiotherapy without a tumor bed boost in patients with primary central nervous system (CNS) germinomas. Methods: We retrospectively reviewed the clinical records of patients with primary CNS germinomas who received short-course induction chemotherapy (2 cycles of cisplatin 20 mg/m 2 plus etoposide 40 or 100 mg/m 2 for 5 days) followed by low-dose radiotherapy (dose: 2340 cGy) without a tumor bed boost. Disease-free survival and overall survival served as the main outcome measures. Results: Between February 2002 and June 2018, 24 patients (20 males and 4 females; median age: 14.1 y; age range: 7.9 to 21.2 y) with pathology-proven CNS germinomas were included. The median follow-up time was 106 months (range: 17 to 169 mo). Isolated and multifocal lesions were identified in 13 and 11 patients, respectively. Tumor location was as follows: pineal gland (n=17), suprasellar region (n=13), periventricular region (n=7), and basal ganglia (n=2). Five patients had increased levels (>5 mIU/mL) of beta-human chorionic gonadotropin (β-hCG), whereas alpha-fetoprotein concentrations were within the reference range in all participants. A total of 16 patients achieved remission after induction chemotherapy. The complete response rates of patients with increased and normal β-hCG levels were 40.0% and 72.2%, respectively ( P =0.208). Low-dose radiotherapy without a tumor bed boost was subsequently delivered to either the whole ventricle (n=16) or the whole brain (n=8), resulting in complete remission in all participants. Compared with patients without increased β-hCG levels, those with β-hCG-secreting germinomas had less favorable 5-year disease-free survival rates (100% vs. 60%, respectively, P =0.000115). Conclusions: Some children with primary CNS germinoma may benefit from short-course induction chemotherapy followed by low-dose radiotherapy to the whole ventricle without a tumor bed boost. The validity of our findings needs to be confirmed in a randomized phase II study for children with β-hCG levels <5 mIU/mL. … (more)
- Is Part Of:
- Journal of pediatric hematology/oncology. Volume 43:Issue 7(2021)
- Journal:
- Journal of pediatric hematology/oncology
- Issue:
- Volume 43:Issue 7(2021)
- Issue Display:
- Volume 43, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 43
- Issue:
- 7
- Issue Sort Value:
- 2021-0043-0007-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-10
- Subjects:
- germinoma -- induction chemotherapy -- low-dose radiotherapy -- prognosis -- beta-human chorionic gonadotropin
Pediatric hematology -- Periodicals
Tumors in children -- Periodicals
618.9215 - Journal URLs:
- http://journals.lww.com/jpho-online/pages/default.aspx ↗
http://gateway.tx.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00043426-000000000-00000 ↗
http://www.jpho-online.com/ ↗
http://journals.lww.com/jpho-online/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPH.0000000000002006 ↗
- Languages:
- English
- ISSNs:
- 1077-4114
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5030.183000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25079.xml